
Bfflist AMO
Finnrick has tested 51 samples from Bfflist AMO across 3 products.
Finnrick Vendor Profile
to
Bfflist AMO
Tracking 3 products
51 total samples tested
Last test 29 Jan 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 37 | 30 Jun 2025 | 29 Jan 2026 | |||||
| Semaglutide | 3 | 29 Jun 2025 | 25 Nov 2025 | |||||
| Tirzepatide | 11 | 11 Jun 2025 | 29 Jan 2026 | |||||
Most recent Bfflist AMO tests
Samples are tested in commercial labs
51
tests
3
products
Scores
AVGMINMAX
First
11 Jun 2025
Last
29 Jan 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 29 Jan 2026 | Retatrutide | View | 20mg | 20.2mg | +1.0% | 99.67% | 209021-10/24/2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 29 Jan 2026 | Retatrutide | View | 20mg | 20mg | 99.71% | 209022 11/10/2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | ||
| 29 Jan 2026 | Retatrutide | View | 12mg | 12.8mg | +6.7% | 99.46% | 129006-12/1/2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 29 Jan 2026 | Tirzepatide | View | 30mg | 28.1mg | -6.3% | 99.90% | 309018-11/22/2025 | Red Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 26 Jan 2026 | Retatrutide | View | 30mg | 29.9mg | -0.3% | 99.70% | 308037-11/10/2025 | Red Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 26 Jan 2026 | Retatrutide | View | 30mg | 26.7mg | -11.0% | 99.90% | 309020-12/26/2025 | No Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 26 Jan 2026 | Retatrutide | View | 30mg | 28.6mg | -4.7% | 99.90% | 309019-12/3/2025 | No Label / Silver Crimp / Blue Cap | Lab G | Public | |
Corrections
- 5 Nov 2025: Retatrutide
- These were remade and reanalyzed by Lab G. They traced the discrepancy to a likely human error during preparation.